I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety and efficacy of concurrent immune checkpoint inhibit..:
Osama Mohamad
;
Alberto Diaz de Leon
;
Samuel Schroeder
...
http://dx.doi.org/10.1080/2162402X.2018.1440168. , 2018
Link:
https://doi.org/10.1080/2162402X.2018.1440168
RT Journal T1
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1b440311a27840808257a962dd3e4584&Exemplar=1&LAN=DE A1 Osama Mohamad A1 Alberto Diaz de Leon A1 Samuel Schroeder A1 Andrew Leiker A1 Alana Christie A1 Elizabeth Zhang-Velten A1 Lakshya Trivedi A1 Saad Khan A1 Neil B Desai A1 Aaron Laine A1 Kevin Albuquerque A1 Puneeth Iyengar A1 Yull Arriaga A1 Kevin Courtney A1 David E. Gerber A1 Hans Hammers A1 Hak Choy A1 Robert Timmerman A1 James Brugarolas A1 Raquibul Hannan PB Taylor & Francis Group YR 2018 K1 hypofractionation K1 immune checkpoint inhibitors K1 immunotherapy K1 ipilimumab K1 nivolumab K1 radiation K1 radiotherapy K1 stereotactic radiation K1 Immunologic diseases. Allergy K1 RC581-607 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://dx.doi.org/10.1080/2162402X.2018.1440168 LK http://dx.doi.org/https://doi.org/10.1080/2162402X.2018.1440168 DO https://doi.org/10.1080/2162402X.2018.1440168 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)